Stock Events

Stock Events

Keros Therapeutics (KROS) Q3 2024 Earnings

7AugConfirmed

Q3 2023

Q4 2023

Q2 2024

Q3 2024

-1.37

-1.32

-1.26

-1.21

Details

Expected EPS

-1.258473

Actual EPS

-1.25

Surprise EPS

0.01

Surprise Percent

+0.67%

Description

Keros Therapeutics (KROS) has reported earnings of -1.25 per share for Q3 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.